Click to Share
 

Friedreich's Ataxia Press Releases

Exclusive News
Topics Locations Industries Dates

By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).
11933682
By Mary Ann Liebert, Inc., publishers
A novel approach to gene therapy that instructs a person’s own cells to produce more of a natural disease-fighting protein could offer a solution to treating many genetic disorders.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share